Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05265910
Status:
COMPLETED
Last Update Posted:
2022-05-03
First Post:
2021-12-14
Brief Title:
A Study Comparing the Efficacy of Pataday Once Daily Relief Extra Strength to Claritin Tablets 24-Hour in Subjects With Allergic Conjunctivitis
Sponsor:
Organization:
Andover Research Eye Institute
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
58
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE4 |
Observational Models:
Time Perspective List:
Who Masked List: